FDA-Inspected Site

Offices for Fertility and Reproductive Medicine, P. C.

5 FDA inspections are on record for Offices for Fertility and Reproductive Medicine, P. C. in New York, United States.

483· Form 483 issued

New York, United States · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2018-01-31.

At a glance

Inspections

5

Form 483s

4

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
16 Jan 2018 – 31 Jan 2018Biologics483View 483 →
2 Mar 2016 – 18 Mar 2016Biologics483View 483 →
8 May 2014 – 12 May 2014BiologicsClean
25 Sep 2012Not recorded483View 483 →
28 Sep 2009Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

31 Jan 2018
21 CFR 1271.47(a)

Donor eligibility procedures

Cited by Amy Kim

31 Jan 2018
21 CFR 1271.47(a)

Donor eligibility procedures

Cited by Amy Kim

31 Jan 2018
21 CFR 1271.50(a)

Responsible person to determine, document

Cited by Amy Kim

31 Jan 2018
21 CFR 1271.50(a)

Responsible person to determine, document

Cited by Amy Kim

31 Jan 2018
21 CFR 1271.85(c)

Reproductive cells or tissues

Cited by Amy Kim

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 1271.47(a)Cited across public-safe Form 483 observations7x
21 CFR 1271.50(a)Cited across public-safe Form 483 observations3x
21 CFR 1271.55(d)(2)Cited across public-safe Form 483 observations2x
21 CFR 1271.85(c)Cited across public-safe Form 483 observations2x
21 CFR 606.160(a)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 4 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat